[1] L. SEAL. PRL-releasing peptide inhibits food intake in male rats via the dorsomedial hypothalamic nucleus and not the paraventricular hypothalamic nucleus.[J]. Endocrinology, 2001, 114 1: 4236-4243. DOI:
10.1210/endo.142.10.8419[2] CHRISTOPHER J LANGMEAD. Characterization of the binding of [125I]-human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor[J]. British Journal of Pharmacology, 2009, 131 4: 683-688. DOI:
10.1038/sj.bjp.0703617[3] MIA ENGSTRÖM. Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors.[J]. Journal of Pharmacology and Experimental Therapeutics, 2003, 305 3: 825-832. DOI:
10.1124/jpet.102.047118[4] L J SEAL. Prolactin releasing peptide (PrRP) stimulates luteinizing hormone (LH) and follicle stimulating hormone (FSH) via a hypothalamic mechanism in male rats.[J]. Endocrinology, 2000, 141 5: 1909-1912. DOI:
10.1210/endo.141.5.7528